| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.38 |
1e-14 |
| mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.29 |
2e-14 |
| mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
2e-11 |
| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
2e-09 |
| mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
2e-06 |
| mRNA |
PD-0325901 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
7e-06 |
| mRNA |
TG-101348 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
3e-05 |
| mRNA |
PLX4720 |
CCLE |
pan-cancer |
AAC |
0.2 |
4e-05 |
| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-05 |
| mRNA |
RO-3306 |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
7e-05 |